AHCOAdaptHealth Corp.

$5.66

AHCO as reported

AdaptHealth Corp. reported $3.29B of revenue over the trailing twelve months, +1.2% on the year before. 11 reported series are charted on this page, each one as filed.

$3.29B

Revenue, trailing twelve months · to Q1 2026 · +1.2% against the twelve months before

Net Income
−$80M

Net Income · −193% year on year · trailing twelve months to Q1 2026

Free Cash Flow
$192M

Free Cash Flow · −30% year on year · trailing twelve months to Q1 2026

Op Margin
2.4%

Op Margin · trailing twelve months to Q1 2026

Every series Ryufin has for AHCO, trailing twelve months
SeriesLatestYear on yearAs of
Revenue$3.29B+1.2%Q1 2026
Net Income−$80M−193%Q1 2026
EPS−$0.59−204%Q1 2026
Gross Margin18%n/aQ1 2026
Op Margin2.4%n/aQ1 2026
Net Margin−2.3%n/aQ1 2026
ROE0.05%n/aQ1 2026
ROA0.07%n/aQ1 2026
ROIC4.1%n/aQ1 2026
Free Cash Flow$192M−30%Q1 2026
P/E17.2n/aQ3 2025

Every figure straight from the statements as filed with the SEC, no scoring, no adjustment. Open a series for its full history.

Revenue & ProfitAdaptHealth Corp. (AHCO)
Revenue (TTM)Net Income (TTM)
Powered byryufin.com